Target intelligence / Profile preview

Ribosomal protein S20 pseudogene 23 (RPS20P23)

Target
RPS20P23
Molecular classification
Pseudogene, Processed pseudogene, Other (not a protein-coding gene or functional RNA)
01

Overview

Ribosomal protein S20 pseudogene 23 (RPS20P23) is a human processed pseudogene that does not code for a functional protein[1][8]. It originates from the parent RPS20 gene, which encodes a component of the 40S ribosomal subunit involved in protein synthesis[3][4]. Like other processed pseudogenes, RPS20P23 is considered nonfunctional in terms of protein-coding capacity and is not recognized as a therapeutic target, enzyme, receptor, or transporter. Some pseudogenes can have regulatory roles or be differentially expressed in tissues, particularly in cancer, but there is no direct evidence for a unique functional or disease role for RPS20P23 itself[1][8]. There are currently no known drugs, mechanisms of action, or clinical biomarkers associated with this pseudogene.

Other names
RPS20_9_932RPS20P23
02

Biological functions

Other (no protein-coding function; may have regulatory or unknown roles as a pseudogene)
03

Disease associations

Other (no established direct disease association; ribosomal protein pseudogenes may be dysregulated in cancer or other diseases, but no data specific to RPS20P23[1][8])

Beyond the preview

Go deeper on Ribosomal protein S20 pseudogene 23 (RPS20P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S20 pseudogene 23 (RPS20P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call